- Home
- PHAT vs CDRO Comparison
PHAT vs CDRO Comparison
Compare PHAT & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | CDRO |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 319.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PHAT | CDRO |
|---|---|---|
| Price | $14.60 | $7.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $17.33 | $9.00 |
| AVG Volume (30 Days) | ★ 777.9K | 52.5K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $147,190,000.00 | ★ $207,789,626.00 |
| Revenue This Year | $218.59 | $10.04 |
| Revenue Next Year | $84.38 | $9.24 |
| P/E Ratio | ★ N/A | $92.97 |
| Revenue Growth | ★ 460.30 | 24.16 |
| 52 Week Low | $2.21 | $5.18 |
| 52 Week High | $16.45 | $8.75 |
Technical Indicators
Market Signals| Indicator | PHAT | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 70.91 |
| Support Level | $14.12 | $6.78 |
| Resistance Level | $16.27 | $7.39 |
| Average True Range (ATR) | 0.74 | 0.36 |
| MACD | -0.11 | 0.09 |
| Stochastic Oscillator | 23.18 | 81.05 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.